跳至主要内容
临床试验/JPRN-C000000279
JPRN-C000000279已完成3 期

Randomized phase III trial of surgery plus neoadjubant TS-1 and cisplatin compared with surgery alone for type 4 and large type 3 gastric cancer: Japan Clinical Oncology Group Study (JCOG 0501) - Randomized phase III trial of surgery plus neoadjubant TS-1 and cisplatin compared with surgery alone for type 4 and large type 3 gastric cancer: Japan Clinical Oncology Group Study (JCOG 0501)

Japan Clinical Oncology Group(JCOG)0 个研究点目标入组 316 人开始时间: 2005年11月8日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
316

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 75years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • (1) synchronous or metachronous (within 5 years) malignancy other than carcinoma in situ (2) pregnant or breast-feeding women (3) severe mental disease (4) systemic administration of corticosteroids, flucytosine, phenytoin or warfarin (5) other severe complications such as paralytic ileus, intensitinal pneumonitis, pulumonary fibrosis, or ischemic heart disease (6) myocardial infarction within six disease-free months (7) positive HBs antigen

研究者

发起方
Japan Clinical Oncology Group(JCOG)

相似试验

Randomized phase III trial of surgery plus... | 临床试验